The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure

This publication has 12 references indexed in Scilit:

• Clinical criteria and biochemical markers for the detection of systolic dysfunction
  Journal of Cardiac Failure, 2000
• Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
  The Lancet, 2000
• Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy
  American Heart Journal, 1999
• The Natriuretic Peptides in Heart Failure: Diagnostic and Therapeutic Potentials
  Proceedings of the Association of American Physicians, 1999
• Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure
  American Journal of Physiology-Heart and Circulatory Physiology, 1998
• Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
  The Lancet, 1997
• Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular Hypertrophy
  Hypertension, 1996
• Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.
  Circulation, 1993
• Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.
  Journal of Clinical Investigation, 1991
• Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the Human
  Science, 1986